TRACON Pharmaceuticals (NASDAQ:TCON) Stock Sees heavy Selling Pressure: Here is Why
Clinical stage biopharmaceutical company focusing on development and commercialisation of unique cancer therapeutics, TRACON Pharmaceuticals (NASDAQ:TCON), on 22nd July, 2021
Read more